| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Virgin Orbit Holdings, Inc. | FORMER DIRECTOR | Common Stock | 125,000 | 29 Dec 2021 | Direct | ||
| Rein Therapeutics, Inc. | Director | Stock Option (right to buy) | 17,500 | 23 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | 23 Jul 2025 | 1 | $0 | 4 | Director | 23 Jul 2025, 19:40 |
| RNTX | Aileron Therapeutics, Inc. | 02 Dec 2024 | 1 | $0 | 4 | Director | 06 Dec 2024, 16:34 |
| RNTX | Aileron Therapeutics, Inc. | 20 Aug 2024 | 1 | $0 | 4 | Director | 22 Aug 2024, 16:07 |
| RNTX | Aileron Therapeutics, Inc. | 28 Feb 2024 | 1 | $0 | 4/A | Director | 10 Apr 2024, 16:15 |
| RNTX | AILERON THERAPEUTICS INC | 28 Feb 2024 | 1 | $0 | 4 | Director | 01 Mar 2024, 16:05 |
| RNTX | AILERON THERAPEUTICS INC | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:16 |
| /report/000121390022000310-von-rickenbach-josef-h-2021-12-29 | Virgin Orbit Holdings, Inc. | 29 Dec 2021 | 1 | +$1,250,000 | 4 | FORMER DIRECTOR | 03 Jan 2022, 18:41 |
| RNTX | AILERON THERAPEUTICS INC | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 19:51 |